Atlas Trials

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Clinical trial NCT01893099 · COMPLETED

Trial details

NCT number
NCT01893099
Sponsor
Centre Hospitalier Universitaire Vaudois
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ocular Melanoma
Start date
2013-06-01
Primary completion
2017-11-28
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.